Novartis to provide 'no profit' COVID-19 drugs to low income countries
- "We shouldn't underestimate the stress that COVID puts particularly on fragile health systems," Hegemann said.
- Novartis's brand-name drugs have had little application in treating the new coronavirus, while its older malaria drug hydroxychloroquine has flopped in some scientific trials against the disease.